JAAD Case Reports (Mar 2021)

Successful transition to encorafenib following vemurafenib-induced drug rash with eosinophilia and systemic symptoms syndrome

  • Peter A. Young, MPAS, BS,
  • Lia C. Keller, MD,
  • Gordon H. Bae, MD

DOI
https://doi.org/10.1016/j.jdcr.2020.12.030
Journal volume & issue
Vol. 9
pp. 42 – 44

Abstract

Read online

No abstracts available.

Keywords